Dianthus Therapeutics DNTH Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's prepaid & other current?
- Dianthus Therapeutics (DNTH) reported prepaid & other current of $7.42M in Q1 2026.
- How has Dianthus Therapeutics's prepaid & other current changed year-over-year?
- Dianthus Therapeutics's prepaid & other current increased by 9.6% year-over-year, from $6.77M to $7.42M.
- What is the long-term trend for Dianthus Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Dianthus Therapeutics's prepaid & other current has grown at a 13.6% compound annual growth rate (CAGR), from $2.69M to $5.09M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.